{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:37:21Z","timestamp":1773801441587,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T00:00:00Z","timestamp":1170720000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1007\/s00415-006-0186-z","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T09:25:18Z","timestamp":1170753918000},"page":"26-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Does modafinil enhance activity of patients with myotonic dystrophy?"],"prefix":"10.1007","volume":"254","author":[{"given":"A.R.","family":"Wintzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,2,6]]},"reference":[{"key":"186_CR1","volume-title":"Myotonic Dystrophy","author":"PS Harper","year":"2001","unstructured":"Harper PS (2001) Myotonic Dystrophy. WB Saunders, London"},{"key":"186_CR2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.56.6.794","volume":"56","author":"MS Damian","year":"2001","unstructured":"Damian MS, Gerlach A, Schmidt F, et al. (2001) Modafinil for excessive daytime sleepiness in Myotonic dystrophy. Neurology 56:794\u2013796","journal-title":"Neurology"},{"key":"186_CR3","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/01.WNL.0000037481.08283.51","volume":"59","author":"JR Macdonald","year":"2002","unstructured":"Macdonald JR, Hill JD, Tarnapolsky MA (2002) Modafinil reduces excessive somnolence and enhances mood in patients with Myotonic dystrophy. Neurology 59:1876\u20131880","journal-title":"Neurology"},{"key":"186_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0960-8966(03)00030-0","volume":"13","author":"K Talbot","year":"2003","unstructured":"Talbot K, Stradling J, Crosby J, et al. (2003) Reduction in excess daytime sleepiness by Modafinil in patients with Myotonic dystrophy. Neuromusc Disorders 13:357\u2013364","journal-title":"Neuromusc Disorders"},{"key":"186_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hec.4730020305","volume":"2","author":"RD Hays","year":"1993","unstructured":"Hays RD, Sherbourne CD, Mazel RM (1993) The Rand 36-item Health Survey 1.0. Health Econ 2:217\u2013227","journal-title":"Health Econ"},{"key":"186_CR6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14:540\u2013545","journal-title":"Sleep"},{"key":"186_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jnnp.74.1.138","volume":"74","author":"SP van der Werf","year":"2003","unstructured":"van der Werf SP, Kalkman J, Bleijenberg G, et al. (2003) The relation between daytime sleepiness, fatigue, and reduced motivation in patients with adult onset Myotonic Dystrophy. J Neurol Neurosurg Psychiatry 74:138\u2013139","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0186-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-006-0186-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0186-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0186-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T17:15:45Z","timestamp":1630430145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-006-0186-z"}},"subtitle":["A double-blind placebo-controlled crossover study"],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1007\/s00415-006-0186-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"1 August 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}